| __timestamp | Teva Pharmaceutical Industries Limited | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1488000000 | 11768000 |
| Thursday, January 1, 2015 | 1525000000 | 15152000 |
| Friday, January 1, 2016 | 2111000000 | 19828000 |
| Sunday, January 1, 2017 | 1848000000 | 25573000 |
| Monday, January 1, 2018 | 1213000000 | 23634000 |
| Tuesday, January 1, 2019 | 1010000000 | 38845000 |
| Wednesday, January 1, 2020 | 997000000 | 50523000 |
| Friday, January 1, 2021 | 967000000 | 75463000 |
| Saturday, January 1, 2022 | 838000000 | 105767000 |
| Sunday, January 1, 2023 | 953000000 | 167512000 |
| Monday, January 1, 2024 | 998000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Teva Pharmaceutical Industries Limited and Xenon Pharmaceuticals Inc. have demonstrated contrasting R&D strategies.
Teva, a global leader in generic and specialty medicines, has seen its R&D expenses fluctuate significantly. From 2014 to 2023, Teva's R&D investment peaked in 2016, with a 42% increase compared to 2014, before gradually declining by 55% by 2022. This trend reflects Teva's strategic shift towards optimizing its portfolio and focusing on core therapeutic areas.
Conversely, Xenon Pharmaceuticals, a clinical-stage biopharmaceutical company, has consistently increased its R&D spending. From 2014 to 2023, Xenon's investment surged by over 1,300%, highlighting its commitment to pioneering treatments for neurological disorders. This steady ascent underscores Xenon's growth trajectory and its focus on innovation.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.